Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI (PROTECT I)

This study has been completed.
Information provided by:
Abiomed Inc. Identifier:
First received: September 24, 2007
Last updated: March 18, 2011
Last verified: March 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):